Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Aqua Bio Technology ASA ( (DE:3FZ) ) is now available.
Aqua Bio Technology ASA has completed a private placement of 2,000,000 new shares at NOK 5.00 per share, aligned with a planned 50:1 reverse share split to be carried out before the transaction’s formal completion. The issuance has diluted existing shareholders, including RH Industri AS and Roger Hofseth, whose combined stake now stands at 464,355 shares, or 8.9% of the company’s shares and voting rights, triggering a mandatory disclosure under Norwegian securities law.
The transaction slightly reshapes ABTEC’s ownership structure and may strengthen its capital base for operations in skincare biotechnology and distribution. The disclosure underscores regulatory transparency requirements in the Norwegian market as significant shareholders pass notifiable thresholds following equity transactions.
More about Aqua Bio Technology ASA
Aqua Bio Technology ASA (ABTEC) is a Norwegian technology and distribution group focused on skincare and nonfood segments. The company serves both B2C and B2B markets, offering freight, customs, and logistics services, and it develops sustainable biotechnology for use in skincare products. ABTEC is listed on the Euronext Expand market in Oslo.
YTD Price Performance: -67.90%
Average Trading Volume: 602,111
Current Market Cap: NOK23.76M
For a thorough assessment of 3FZ stock, go to TipRanks’ Stock Analysis page.